Cormorant Private Healthcare Fund III LP's Net Worth
$767 Million
Who is Cormorant Private Healthcare Fund III LP?
Cormorant Private Healthcare Fund III LP has an estimated net worth of $767 Million. This is based on reported shares across multiple companies, which include Prometheus Biosciences, Inc., Ambrx Biopharma, Inc., Design Therapeutics, Inc., Icosavax, Inc., Ventyx Biosciences, Inc., Tyra Biosciences, Inc., Monte Rosa Therapeutics, Inc., Verve Therapeutics, Inc., Immuneering Corp, Pyxis Oncology, Inc., Elevation Oncology, Inc., Ambrx Biopharma Inc., Biomea Fusion, Inc., Rain Therapeutics Inc., Olema Pharmaceuticals, Inc., and MoonLake Immunotherapeutics.
SEC CIK
Cormorant Private Healthcare Fund III LP's CIK is 0001817320
Past Insider Trading and Trends
2021 was Cormorant Private Healthcare Fund III LP's most active year for acquiring shares with 26 total transactions. Cormorant Private Healthcare Fund III LP's most active month to acquire stocks was the month of March. 2021 was Cormorant Private Healthcare Fund III LP's most active year for disposing of shares, totalling 14 transactions. Cormorant Private Healthcare Fund III LP's most active month to dispose stocks was the month of February. 2023 saw Cormorant Private Healthcare Fund III LP paying a total of $155,571,161.49 for 13,032,174 shares, this is the most they've acquired in one year. In 2021 Cormorant Private Healthcare Fund III LP cashed out on 15,787,341 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Prometheus Biosciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.22M |
$19.00 |
—
| 2.22M |
Mar 16
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ambrx Biopharma, Inc. (AMAM) Snapshot price: $27.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.17% | 1.31M |
$6.99 | $9,139,541.93 | 11.23M |
Oct 23
| |||
No matching records found |
Design Therapeutics, Inc. (DSGN) Snapshot price: $2.295
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.11M |
$20.00 |
—
| 5.11M |
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Icosavax, Inc. (ICVX) Snapshot price: $15.24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 426.39K |
—
|
—
| 426.39K |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.41M |
$16.00 |
—
| 1.41M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |